We then investigated the consequences of OGA downregulation on the entry into TIS of colon cancer cells, hypothesizing that it could potentially delay or prevent the establishment of the senescence phenotype in response to low-dose chemotherapy. The gene discussed is OGA; the disease is colonic neoplasm.